ArticleFrontiers in medicine2026
Case Report: A "visceral vasculitis storm" in Systemic Lupus Erythematosus: simultaneous enteritis, ureteritis, and splenic infarction in a pediatric patient.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Systemic Lupus Erythematosus (SLE) is a multi-system autoimmune disease. Although lupus enteritis is a recognized manifestation of mesenteric vasculitis, lupus ureteritis is rare. The simultaneous occurrence of both, termed a "visceral vasculitis storm," poses a significant diagnostic challenge. Clinicians often struggle to differentiate primary ureteritis from secondary mechanical compression caused by intestinal edema (the "monistic" view). Case presentation: A 16-year-old girl with a history of transient ptosis and positive ANA/dsDNA results 4 months prior to the current presentation, presented with abdominal pain, fever, and transient dysuria. Initial outpatient CT revealed bilateral hydroureteronephrosis. During hospitalization, the patient's condition deteriorated despite antibiotic therapy. A repeat contrast-enhanced CT (CECT) demonstrated the classic "target sign" in the bowel wall, splenic infarction, and crucially, distinct ureteral wall enhancement. Laboratory findings showed a "high CRP/low PCT" dissociation and a markedly elevated D-Dimer (13.74 μg/mL). The diagnosis was revised to SLE with diffuse visceral vasculitis. The patient responded rapidly to methylprednisolone pulse therapy and IVIG, followed by maintenance therapy with Cyclophosphamide and the dual BLyS/APRIL inhibitor Telitacicept. Conclusion: This case highlights that ureteral wall enhancement on CECT can serve as a potentially useful radiologic clue for primary lupus ureteritis. Recognizing the "visceral vasculitis storm" is essential to avoid the pitfalls of diagnostic monism and to initiate aggressive immunosuppressive therapy promptly to prevent irreversible organ damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.